Advanced search
Publication Cover
Leukemia & Lymphoma Volume 63, 2022 - Issue 4
Submit an article Journal homepage
410
Views
2
CrossRef citations to date
0
Altmetric
Original Articles

CD5-negative mantle cell lymphoma: clinicopathologic features of an indolent variant that confers a survival advantage

Arshia Soleimania Greenebaum Comprehensive Cancer Center, University of Maryland Medical Center, Baltimore, MD, USA
,
Alba Navarrob Hematopathology Section, Department of Anatomic Pathology, Hospital Clínic, Institut d’Investigacions Biomédiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain
,
Delong Liuc Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA
,
Sarah E. M. Hermanc Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA
,
Shih-Sung Chuangd Department of Pathology, Chi-Mei Medical Center, Tainan, Taiwan
,
Irma Slavutskye Laboratorio de Genética de Neoplasias Linfoides, Instituto de Medicina Experimental, CONICET-Academia Nacional de Medicina, Buenos Aires, Argentina
,
Marina Narbaitzf División Patología, Instituto de Investigaciones Hematológicas, ANM, Buenos Aires, Argentina
,
Hana Safahg Section of Hematology and Medical Oncology, Department of Medicine, Tulane University, New Orleans, LA
,
John Schmiegh Department of Pathology, Tulane University, New Orleans, LA, USA
,
John Lefantei Department of Biostatistics of Pathology, Tulane University, New Orleans, LA, USA
,
Mark Roschewskij Department of Biostatistics and Data Science, Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USAORCID Iconhttps://orcid.org/0000-0003-0278-2635
ORCID Icon,
Wyndham H. Wilsonj Department of Biostatistics and Data Science, Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
,
Adrian Wiestnerc Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA
&
Nakhle S. Sabag Section of Hematology and Medical Oncology, Department of Medicine, Tulane University, New Orleans, LACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-3206-2575
ORCID Icon show all
Pages 911-917 | Received 12 Apr 2021, Accepted 25 Oct 2021, Published online: 15 Nov 2021

References

  • Swerdlow SH, Campo E, Pileri SA, et al. The 2016 revision of the world health organization classification of lymphoid neoplasms. Blood. 2016;127(20):2375–2390.
  • Institute NC. SEER Research Data: Surveillance, Epidemiology, and End Results (SEER) Program https://seer.cancer.gov/seertools/hemelymph/51f6cf57e3e27c3994bd5357/
  • Furtado M, Rule S. Indolent mantle cell lymphoma. Haematologica. 2011;96(8):1086–1088.
  • Hoster E, Klapper W, Hermine O, et al. Confirmation of the mantle-cell lymphoma international prognostic index in randomized trials of the european Mantle-Cell lymphoma network. J Clin Oncol. 2014;32(13):1338–1346.
  • Hashimoto Y, Omura H, Tanaka T, et al. CD5-negative mantle cell lymphoma resembling extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue : a case report. J Clin Exp Hematop. 2012;52(3):185–191.
  • Zhao XF. Pitfalls in diagnostic hematopathology: part I. Int J Clin Exp Pathol. 2009;2(1):11–20.
  • Liu Z, Dong HY, Gorczyca W, et al. CD5- mantle cell lymphoma. Am J Clin Pathol. 2002;118(2):216–224.
  • Shih A, Bledsoe J, McKelvie P, et al. CD5-negative mantle cell lymphoma shows a less aggressive outcome and variable SOX11 staining. J Hematopathol. 2017;10(2):49.
  • Miao Y, Lin P, Saksena A, et al. CD5-negative mantle cell lymphoma: Clinicopathologic correlations and outcome in 58 patients. Am J Surg Pathol. 2019;43(8):1052–1060.
  • Chuang SS, Huang WT, Hsieh PP, et al. Mantle cell lymphoma in Taiwan: clinicopathological and molecular study of 21 cases including one cyclin D1-negative tumor expressing cyclin D2. Pathol Int. 2006;56(8):440–448.
  • Navarro A, Clot G, Royo C, et al. Molecular subsets of mantle cell lymphoma defined by the IGHV mutational status and SOX11 expression have distinct biologic and clinical features. Cancer Res. 2012;72(20):5307–5316.
  • Saba NS, Liu D, Herman SE, et al. Pathogenic role of B-cell receptor signaling and canonical NF-κB activation in mantle cell lymphoma . Blood. 2016;128(1):82–92.
  • Ondrejka SL, Lai R, Smith SD, et al. Indolent mantle cell leukemia: a clinicopathological variant characterized by isolated lymphocytosis, interstitial bone marrow involvement, kappa light chain restriction, and good prognosis. Haematologica. 2011;96(8):1121–1127.
  • Jain P, Wang M. Mantle cell lymphoma: 2019 update on the diagnosis, pathogenesis, prognostication, and management. Am J Hematol. 2019;94(6):710–725.
  • Hsu P, Yang T, Sheikh-Fayyaz S, et al. Mantle cell lymphoma with in situ or mantle zone growth pattern: a study of five cases and review of literature. Int J Clin Exp Pathol. 2014;7(3):1042–1050.
  • Carvajal-Cuenca A, Sua LF, Silva NM, et al. In situ mantle cell lymphoma: clinical implications of an incidental finding with indolent clinical behavior. Haematologica. 2012;97(2):270–278.
  • Fernandez V, Salamero O, Espinet B, et al. Genomic and gene expression profiling defines indolent forms of mantle cell lymphoma. Cancer Res. 2010;70(4):1408–1418.
  • Martin P, Chadburn A, Christos P, et al. Outcome of deferred initial therapy in mantle-cell lymphoma. J Clin Oncol. 2009;27(8):1209–1213.
  • Orchard J, Garand R, Davis Z, et al. A subset of t(11;14) lymphoma with mantle cell features displays mutated IgVH genes and includes patients with good prognosis, nonnodal disease. Blood. 2003;101(12):4975–4981.
  • Calissano C, Damle RN, Marsilio S, et al. Intraclonal complexity in chronic lymphocytic leukemia: fractions enriched in recently born/divided and older/quiescent cells. Mol Med. 2011;17(11-12):1374–1382.
  • Herishanu Y, Perez-Galan P, Liu D, et al. The lymph node microenvironment promotes B-cell receptor signaling, NF-kappaB activation, and tumor proliferation in chronic lymphocytic leukemia. Blood. 2011;117(2):563–574.
  • Herndon TM, Chen SS, Saba NS, et al. Direct in vivo evidence for increased proliferation of CLL cells in lymph nodes compared to bone marrow and peripheral blood. Leukemia. 2017;31(6):1340–1347.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.